48 related articles for article (PubMed ID: 26560803)
1. The health status of a village population, 7 years after a major Q fever outbreak.
Morroy G; Van Der Hoek W; Nanver ZD; Schneeberger PM; Bleeker-Rovers CP; Van Der Velden J; Coutinho RA
Epidemiol Infect; 2016 Apr; 144(6):1153-62. PubMed ID: 26560803
[TBL] [Abstract][Full Text] [Related]
2. Population Screening for Chronic Q-Fever Seven Years after a Major Outbreak.
Morroy G; van der Hoek W; Albers J; Coutinho RA; Bleeker-Rovers CP; Schneeberger PM
PLoS One; 2015; 10(7):e0131777. PubMed ID: 26132155
[TBL] [Abstract][Full Text] [Related]
3. The health status of Q-fever patients after long-term follow-up.
Morroy G; Peters JB; van Nieuwenhof M; Bor HH; Hautvast JL; van der Hoek W; Wijkmans CJ; Vercoulen JH
BMC Infect Dis; 2011 Apr; 11():97. PubMed ID: 21501483
[TBL] [Abstract][Full Text] [Related]
4. The Qure study: Q fever fatigue syndrome--response to treatment; a randomized placebo-controlled trial.
Keijmel SP; Delsing CE; Sprong T; Bleijenberg G; van der Meer JW; Knoop H; Bleeker-Rovers CP
BMC Infect Dis; 2013 Mar; 13():157. PubMed ID: 23536997
[TBL] [Abstract][Full Text] [Related]
5. Acute Q Fever Case Detection among Acute Febrile Illness Patients, Thailand, 2002-2005.
Greiner AL; Bhengsri S; Million M; Edouard S; Thamthitiwat S; Clarke K; Kersh GJ; Gregory CJ; Raoult D; Parola P
Am J Trop Med Hyg; 2018 Jan; 98(1):252-257. PubMed ID: 29141767
[TBL] [Abstract][Full Text] [Related]
6. Identification of risk factors for chronic Q fever, the Netherlands.
Kampschreur LM; Dekker S; Hagenaars JC; Lestrade PJ; Renders NH; de Jager-Leclercq MG; Hermans MH; Groot CA; Groenwold RH; Hoepelman AI; Wever PC; Oosterheert JJ
Emerg Infect Dis; 2012 Apr; 18(4):563-70. PubMed ID: 22469535
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of Screening Program for Chronic Q Fever, the Netherlands.
de Boer PT; de Lange MMA; Wielders CCH; Dijkstra F; van Roeden SE; Bleeker-Rovers CP; Oosterheert JJ; Schneeberger PM; van der Hoek W
Emerg Infect Dis; 2020 Feb; 26(2):238-246. PubMed ID: 31961297
[TBL] [Abstract][Full Text] [Related]
8. Assessing health status and quality of life of Q-fever patients: the Nijmegen Clinical Screening Instrument versus the Short Form 36.
van Loenhout JA; Paget WJ; Sandker GW; Hautvast JL; van der Velden K; Vercoulen JH
Health Qual Life Outcomes; 2013 Jul; 11():112. PubMed ID: 23826639
[TBL] [Abstract][Full Text] [Related]
9. Long-term health outcomes of Q-fever fatigue syndrome patients.
Spronk I; Brus IM; de Groot A; Tieleman P; Olde Loohuis AGM; Haagsma JA; Polinder S
Epidemiol Infect; 2023 Sep; 151():e179. PubMed ID: 37724460
[TBL] [Abstract][Full Text] [Related]
10. Fulminant hepatic failure and acute renal failure as manifestations of concurrent Q fever and cytomegalovirus infection: a case report.
Hsu JY; Tsai CC; Tseng KC
BMC Infect Dis; 2014 Dec; 14():651. PubMed ID: 25487053
[TBL] [Abstract][Full Text] [Related]
11. Q fever in the Netherlands: public perceptions and behavioral responses in three different epidemiological regions: a follow-up study.
Bults M; Beaujean D; Wijkmans C; Richardus JH; Voeten H
BMC Public Health; 2014 Mar; 14():263. PubMed ID: 24645896
[TBL] [Abstract][Full Text] [Related]
12. Work participation, social roles, and empowerment of Q-fever fatigue syndrome patients ≥10 years after infection.
Brus IM; Teng ASJ; Heemskerk SCM; Polinder S; Tieleman P; Hartman E; Dollekens B; Haagsma JA; Spronk I
PLoS One; 2024; 19(4):e0302573. PubMed ID: 38687756
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid Antibody Syndrome With Valvular Vegetations in Acute Q Fever.
Million M; Thuny F; Bardin N; Angelakis E; Edouard S; Bessis S; Guimard T; Weitten T; Martin-Barbaz F; Texereau M; Ayouz K; Protopopescu C; Carrieri P; Habib G; Raoult D
Clin Infect Dis; 2016 Mar; 62(5):537-44. PubMed ID: 26585519
[TBL] [Abstract][Full Text] [Related]
14. Cytometry profiling of
Raju Paul S; Scholzen A; Reeves PM; Shepard R; Hess JM; Dzeng RK; Korek S; Garritsen A; Poznansky MC; Sluder AE
Front Immunol; 2023; 14():1249581. PubMed ID: 37885896
[TBL] [Abstract][Full Text] [Related]
15. Natural Exposure- and Vaccination-Induced Profiles of
Raju Paul S; Scholzen A; Mukhtar G; Wilkinson S; Hobson P; Dzeng RK; Evans J; Robson J; Cobbold R; Graves S; Poznansky MC; Garritsen A; Sluder AE
Front Immunol; 2022; 13():886698. PubMed ID: 35812430
[TBL] [Abstract][Full Text] [Related]
16. Impact of Q-fever on physical and psychosocial functioning until 8 years after Coxiella burnetii infection: An integrative data analysis.
Reukers DFM; van Jaarsveld CHM; Akkermans RP; Keijmel SP; Morroy G; van Dam ASG; Wever PC; Wielders CCH; van der Velden K; van Loenhout JAF; Hautvast JLA
PLoS One; 2022; 17(2):e0263239. PubMed ID: 35108330
[TBL] [Abstract][Full Text] [Related]
17. Whole Blood Interferon γ Release Is a More Sensitive Marker of Prior Exposure to
Scholzen A; de Vries M; Duerr HP; Roest HJ; Sluder AE; Poznansky MC; Kouwijzer MLCE; Garritsen A
Front Immunol; 2021; 12():701811. PubMed ID: 34394097
[TBL] [Abstract][Full Text] [Related]
18. Long-term impact of a Q-fever outbreak: An evaluation of health symptoms, health-related quality of life, participation and health care satisfaction after ten years.
Bronner MB; Haagsma JA; Dontje ML; Barmentloo L; Kouwenberg RMCEJ; Olde Loohuis AGM; de Groot A; Erasmus V; Polinder S
J Psychosom Res; 2020 Dec; 139():110258. PubMed ID: 33069049
[TBL] [Abstract][Full Text] [Related]
19. Coxiella burnetii Epitope-Specific T-Cell Responses in Patients with Chronic Q Fever.
Scholzen A; Richard G; Moise L; Hartman E; Bleeker-Rovers CP; Reeves PM; Raju Paul S; Martin WD; De Groot AS; Poznansky MC; Sluder AE; Garritsen A
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331958
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
